Phosphoenix funding adds €1.3 million for first-human study preparation, while preclinical signals cannot establish safety or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results